Cargando…
Structure-Guided Design of Selective Epac1 and Epac2 Agonists
The second messenger cAMP is known to augment glucose-induced insulin secretion. However, its downstream targets in pancreatic β-cells have not been unequivocally determined. Therefore, we designed cAMP analogues by a structure-guided approach that act as Epac2-selective agonists both in vitro and i...
Autores principales: | Schwede, Frank, Bertinetti, Daniela, Langerijs, Carianne N., Hadders, Michael A., Wienk, Hans, Ellenbroek, Johanne H., de Koning, Eelco J. P., Bos, Johannes L., Herberg, Friedrich W., Genieser, Hans-Gottfried, Janssen, Richard A. J., Rehmann, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300089/ https://www.ncbi.nlm.nih.gov/pubmed/25603503 http://dx.doi.org/10.1371/journal.pbio.1002038 |
Ejemplares similares
-
A Membrane Permeable Prodrug of S223 for Selective Epac2 Activation in Living Cells
por: Xu, Yunjian, et al.
Publicado: (2019) -
Epac-Inhibitors: Facts and Artefacts
por: Rehmann, Holger
Publicado: (2013) -
Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1
por: Parnell, Euan, et al.
Publicado: (2017) -
EPAC in Nice
Publicado: (1990) -
EPAC impact
Publicado: (1994)